Strontium ranelate (Protos) for postmenopausal osteoporosisStrontium ranelate (Protos) for postmenopausal osteoporosis

Published 2010-04-23 00:00:00

New information relevant to this topic has become available since this RADAR review was published in November 2007.

Links to some relevant resources are provided below.

Category

Title

Date

TGA-approved Product Information

Strontium ranelate (Protos), last amended 18 July 2008

July 2008

Australian guidelines

Clinical guideline for the prevention and treatment of osteoporosis in post-menopausal women and older men

February 2010

Australian Adverse Drug Reactions Bulletin

Severe skin reactions and venous thromboembolism with strontium ranelate (Protos) (Volume 27, Number 3)

June 2008

Other NPS publications about osteoporosis drugs

 

 

RSS FeedRSS feed

Date published: 2010-04-23 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.